Medical News Today: Type 1 diabetes: Drug delays onset by 2 years

0
3

A placebo-controlled, double-blind trial finds that teplizumab delays the onset of type 1 diabetes by a median of 2 years among high-risk individuals.

Source link

Advertisement

LEAVE A REPLY

Please enter your comment!
Please enter your name here